Field Trials

  • Pedro L. Alonso
  • John J. Aponte
Part of the Methods in Molecular Medicine™ book series (MIMM, volume 72)


Current malaria control strategies are based on interventions aimed at either reducing exposure to infectious bites or at chemosupressing the parasite while in the host. In brief, the most commonly used methods to reduce exposure have relied on trying to reduce the number of adult vectors with the use of insecticides, often through residual indoor spraying, or aiming to reduce human vector contact through bednets, repellents, or insecticide-treated materials. Measures aimed against the parasite are based on the use of drugs either as treatment or as prophylaxis. The emergence and spread of resistance against the most commonly used drugs as well as the limitations in the use of insecticides, coupled with the technological developments of the last 30 years, have accelerated the impetus to develop and test new drugs and vaccines against malaria.


Malaria Control Malaria Vaccine Entomological Inoculation Rate Vector Control Measure Transmission Blocking Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    World Health Organization (1997) Guidelines for the Evaluation ofPlasmodium falciparum Asexual Blood-Stage Vaccines in Populations Exposed to Natural Infection. Document TDR/MAL/VAC/97.Google Scholar
  2. 2.
    Alonso, P. L., Molyneaux, M. E., and Smith, T. (1995) Design and methodology of field-based intervention trials of malaria vaccines. Parasitol. Today 11, 197–200.CrossRefGoogle Scholar
  3. 3.
    World Health Organization (1992b) Good manufacturing practices for biological products. Annex 1.WHO Tech. Rep. Ser. 822.Google Scholar
  4. 4.
    Valero, M. V., Amador, L. R., Galindo, C., Figueroa, J., Bello, M. S., Murillo, L. A., et al. (1993) Vaccination with SPf66, a chemically synthesised vaccine, against P. falciparum malaria in Colombia. Lancet 341, 705–710.CrossRefPubMedGoogle Scholar
  5. 5.
    Acosta, C. J., Galindo, C., Schellenberg, D. M., Kahigwa, E., Urassa, H., Aponte, J. J., Armstrong-Schellenberg, J. R., et al. (1998) Evaluation of the SPF66 vaccine for malaria control when delivered through the EPI scheme in Tanzania Trop. Med. Int. Health 4, 368–376.CrossRefGoogle Scholar
  6. 6.
    World Health Organization (1993) Framework for Evaluating a Vaccine for the EPI. WHO/EPI/ GEN/93.5.Google Scholar
  7. 7.
    Alonso, P. L., Tanner, M., Smith, T., Hayes, R. J., Armstrong-Schellenberg, J. R., Lopez, M. C., et al. (1994) A Trial of the synthetic malaria vaccine SPF66 in Tanzania: rationale and design. Vaccine 12, 181–186.CrossRefPubMedGoogle Scholar
  8. 8.
    Alonso, P. L., Smith, T., Armstrong-Schellenberg, J. R., Masanja, H., Mwankusye, S., Urassa, H., et al. (1994) Randomised trial of efficacy of SPF66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania. Lancet 344, 1175–1181CrossRefPubMedGoogle Scholar
  9. 9.
    Menendez, C. (1995) Malaria during pregnancy: a priority area of malaria research and control. Parasitol. Today 11, 178–183.CrossRefPubMedGoogle Scholar
  10. 10.
    Smith P. G. and Hayes, R.J. (1991) Design and conduct of field trials of malaria vaccines, in Malaria: Waiting for the Vaccine. (Targett, G. A. T., ed.), Wiley, New York, pp. 199–215.Google Scholar
  11. 11.
    Stoute, J. A., Slaoui, M., Heppner, G., Momin, P., Kester, K. E., Desmons, P., et al. (1997) A preliminary evalaution of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N. Engl. J. Med. 336, 86–91.CrossRefPubMedGoogle Scholar
  12. 12.
    D’Alessandro, U., et al. (1995) Efficacy trial of malaria vaccine SPf66 in Gambian infants. Lancet 346, 462–467.CrossRefPubMedGoogle Scholar
  13. 13.
    Nosten, F., et al. (1996) Randomized double blind placebo controlled trial of SPf66 malaria vaccine in children in North Western Thailand. Lancet 348, 701–707.CrossRefPubMedGoogle Scholar
  14. 14.
    World Health Organization (1986) Sample Size Determination. A User’s Manual. WHO Epidemiology and Statistical Methodology Unit. Document WHO/HST/ESM86.1.Google Scholar
  15. 15.
    Smith, P. G. and Morrow, R. H. (1996) Methods for Field Trials of Interventions Against Tropical Google Scholar
  16. 16.
    ICH (1997) Harmonised Tripartite Guideline for Good Clinical Practice, Bookwood medical publications Ltd, Second Edition.Google Scholar
  17. 17.
    Council of International Organizations of Medical Sciences (1993) International Ethical Guidelines for Biomedical Research Involving Human Subjects. CIOMS, Geneva.Google Scholar
  18. 18.
    World Health Organization (1989) Guidelines for the Evaluation of Plasmodium falciparum Asexual Blood-Stage Vaccines in Populations Exposed to Natural Infection. Document TDR/MAP/SVE/PF/89.5.Google Scholar
  19. 19.
    World Health Organization (1992) Guidelines for Community-Based Trials of Vaccines Against the Sexual Stages of Malaria Parasites. Document TDR/CTD/TBV/92.Google Scholar
  20. 20.
    Alonso, P. L., Lindsay, S.W., Armstrong, J. R. M., Conteh, M., Hill, A. G., David P. H., et al. (1991) The effect of insecticide-treated bednets on mortality of Gambian children. Lancet 337, 1499–1502.CrossRefPubMedGoogle Scholar
  21. 21.
    Alonso, P. L., Lindsay, S. W., Armstrong-Schellenberg, J. R., Keita, K., Gomez, P., Shenton, F. C., et al. (1993) The impact of the interventions on mortality and morbidity from malaria Trans. Roy. Soc. Trop. Med. Hyg. 87, 37–44.CrossRefPubMedGoogle Scholar
  22. 22.
    Smith, T., Armstrong, J., and Hayes, R. (1997) Attributable fraction estimates and case definitions for malaria in endemic areas Stat. Med. 13, 2345–2358.CrossRefGoogle Scholar
  23. 23.
    Armstrong, J., Smith, T., Alonso, P. L., and Hayes, R. (1994) What is clinical malaria? Finding case definition for field research in highly endemic areas Parasitol. Today 10, 439–442.CrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2002

Authors and Affiliations

  • Pedro L. Alonso
    • 1
    • 2
  • John J. Aponte
    • 3
  1. 1.Epidemiology and Biostatistics Unit, Hospital ClinicUniversity of BarcelonaBarcelonaSpain
  2. 2.Centro de Investigacao em Saude da ManhicaHospital Clinic Collaborative ProgrammeMaputoMozambique
  3. 3.Unidad de Epidemiología, Hospital ClinicUniversidad de BarcelonaBarcelona

Personalised recommendations